Ducommun is a mission-critical aerospace and defense supplier with a strong strategic moat, improving margins, and defense-driven backlog visibility, but current valuation leaves only modest probability-weighted upside after a powerful share-price run.
Ducommun Incorporated is a leading global provider of engineering and manufacturing services, specializing in high-performance products and high-cost-of-failure applications.[1, 2] The company operates primarily within the aerospace and defense (A&D) sector, generating revenues through two principal business segments: Electronic Systems and Structural Systems.[2, 3, 4]
Geographically, operations are heavily concentrated within the United States, utilizing more than twenty domestic manufacturing facilities.[5] Ducommun’s primary customer base includes defense giants and commercial aerospace leaders.[5, 6] Over many decades, the company has cultivated deep relationships with key customers like Boeing, Airbus, and Raytheon Technologies (RTX), which historically account for a combined pro forma revenue of approximately $425 million.[5] Its most critical commercial end markets span narrowbody and widebody passenger jet programs, such as the Boeing 737 MAX, Boeing 787, Airbus A220, and Airbus A320 family.[7, 8] On the military side, the company is highly embedded across mission-critical platforms, including the F-35 Joint Strike Fighter, Apache and Blackhawk helicopters, and priority missile defense programs such as the AMRAAM, Patriot, Tomahawk, SM3, SM6, and THAAD.[2, 6, 7]
Customers select Ducommun over lower-cost alternative contract manufacturers due to several critical factors:
* Highly Specialized Engineering and IP: The company owns design intellectual property (IP) and proprietary trade secrets across illuminated panels, radiofrequency (RF) switches, and motion controllers.[2, 6, 9]
* High Cost of Failure: In mission-critical environments where component failure is not an option, Ducommun’s stringent quality control and high-reliability production models are non-negotiable for defense agencies and OEMs.[1, 2]
* Vertical Integration: Ducommun acts as a full-service, concept-to-production partner, helping OEMs reduce vendor count and compress product lead times.[5]
* Established Certification and Regulatory Barriers: The intense regulatory environment (including AS9100, NADCAP, and DFARS compliance) restricts the qualified supplier pool, locking in Ducommun as a sole-source supplier on key platforms.[9, 10]
| Segment | Share of Q1 2026 Revenue | Key Products & Services | Primary End Markets |
|---|---|---|---|
| Electronic Systems | 56.3% [4] | Printed circuit board assemblies, custom HMI solutions, ruggedized interconnects, electromechanical RF switches, brushless DC motors, resolvers [2, 11] | Missile defense systems, military fixed-wing and rotorcraft, commercial avionics, industrial, deep space [2] |
| Structural Systems | 43.7% [4] | SPF titanium hot-formed parts, complex aluminum structures, VersaCore composite assemblies, structural panels [11] | Commercial narrowbody & widebody passenger jets, business jets, military transport aircraft, hypersonics [7, 11, 12] |
Ducommun sells highly engineered hardware divided into distinct structural and electronic categories. Under Electronic Systems, the company manufactures custom human-machine interface (HMI) solutions, including illuminated panels, switch matrices, pushbuttons, and keyboards designed for harsh military aircraft and cockpit environments.[2] It also designs electromechanical RF switches for radar, broadband communication, and electronic warfare applications, alongside custom brushless DC motors and resolvers for precision motion control.[2] Under Structural Systems, the product suite includes complex metallic and composite configurations.[11] Leveraging superplastic forming (SPF) and titanium hot forming, Ducommun produces lightweight, high-temperature structural components for advanced commercial propulsion systems and hypersonic defense platforms.[11, 12] The company also utilizes proprietary VersaCore composite technology to manufacture highly durable, aerodynamic flight surfaces and structural panels.[11, 13]
Ducommun's economic moat is primarily built on high customer switching costs and strict regulatory certification barriers.[10] Aerospace and defense manufacturing is governed by rigorous quality standards.[10] Gaining approval to supply components for major commercial or military programs requires qualifications such as AS9100 and NADCAP certifications, alongside compliance with Defense Federal Acquisition Regulation Supplement (DFARS) standards.[10] Achieving these credentials typically requires two to five years and capital expenditures ranging from $250,000 to $1.5 million per product configuration.[10]
Once a supplier is designated as the qualified source on an active military program or commercial airframe, OEMs are highly reluctant to switch due to the risk of production delays, re-certification costs, and potential regulatory non-compliance.[5, 10] This post-design lock-in is reinforced by long-term contract agreements, which typically span three to seven years, creating a highly recurring revenue stream.[9, 10] Scale economies also act as a strong barrier, as the company's vast domestic manufacturing footprint and advanced machining capabilities allow it to absorb fixed overhead far more efficiently than smaller competitors.[5, 10] Furthermore, Ducommun owns sole-source design IP for approximately 23% of its product portfolio, completely insulating these programs from competitive bidding.[2, 8, 9]
The addressable market for Ducommun's products is expanding, driven by structural shifts in both defense spending and commercial aviation logistics. The global defense electronics market represents a massive opportunity, estimated at approximately $185 billion in 2025 and projected to grow at a compound annual growth rate (CAGR) of 5.0% to 5.8% through 2035.[14] This growth is driven by rising electronic complexity across aircraft, missiles, radar installations, and distributed sensing architectures.[14] Additionally, the US defense budget remains a primary funding engine, reaching approximately $858 billion in FY2025, with the Missile Defense Agency (MDA) alone representing an $11.6 billion addressable sub-segment.[5]
On the commercial side, global narrowbody fleet expansion and the retirement of older, less fuel-efficient airframes underpin a strong demand recovery.[5] With Boeing and Airbus targeting aggressive production rate ramps for the 737 MAX and A320neo, Ducommun's established positions on these platforms provide a long-term growth runway.[5]
Ducommun operates in a fragmented contract manufacturing and tier-component supplier landscape.[14] Key publicly traded peers and competitors include Moog Inc. (MOG.A), Hexcel Corporation (HXL), Kratos Defense & Security Solutions (KTOS), CPI Aerostructures (CVU), StandardAero (SARO), and Loar Group (LOAR).[15, 16, 17]
When compared to its competitors, Ducommun is uniquely positioned as a balanced hybrid provider of both electronics and structural assemblies, whereas peers like Hexcel focus exclusively on structures (composites) or Moog on precision actuation.[5, 17] In comparison to the newly listed Loar Group, Ducommun currently posts lower net profit margins but trades at a more modest price-to-sales multiple.[16]
A central pillar of Ducommun's strategic positioning is its "offloading" strategy with military primes.[13, 18] As major defense primes (such as Lockheed Martin and Raytheon) face severe capacity constraints and labor shortages in their own factories, they are actively choosing to exit non-core assembly manufacturing.[13] Ducommun is winning market share by taking on these outsourced work packages, moving them into its lower-cost manufacturing footprint.[13] Given that Ducommun's factories possess at least 30% conservative capacity headroom, it is uniquely positioned to capture this outsourced volume without requiring substantial immediate capital investments.[8]
Ducommun reported its first-quarter 2026 financial results on May 12, 2026, for the period ending April 4, 2026.[4, 19, 20] The company posted a net revenue of $209.02 million, representing an 8.6% year-over-year increase compared to the $192.48 million recorded in the first quarter of 2025.[4, 19]
Gross profit rose to $56.23 million, maintaining a strong gross margin of 26.90%, up 70 basis points from 26.20% in the prior-year period.[19, 21] Operating income surged to $15.71 million, representing 7.5% of revenue, compared to $5.04 million (2.6% of revenue) in the first quarter of 2025.[19]
On a GAAP basis, net income was $9.92 million, or $0.64 per diluted share, a substantial increase from the GAAP net income of $1.40 million ($0.09 per diluted share) in the comparable period of 2025.[4, 19] This strong bottom-line performance was primarily driven by higher manufacturing volumes, lower manufacturing overhead, and a favorable product mix toward high-margin defense systems.[19]
The Q1 2026 results presented a mixed outcome relative to consensus Wall Street estimates. Net revenue of $209.02 million surpassed analyst expectations of $199.65 million by 4.7%, marking the company's 20th consecutive quarter of year-over-year top-line growth.[22, 23]
On the earnings front, the performance was subject to consensus interpretation due to a prior restatement.[24] On an adjusted non-GAAP basis, Ducommun posted an EPS of $0.75, which beat expectations of $0.68 to $0.72 in some datasets.[20, 22] However, other consensus trackers, which had expected an EPS of $0.85, flagged the $0.75 print as an 11.76% negative surprise.[23, 25] This discrepancy was caused by the timing of analyst model adjustments following the company's stock-based compensation accounting change announced on May 1, 2026.[24, 26]
For the full fiscal year 2026, management reiterated its target of mid-to-high single-digit revenue growth.[7, 8] Analysts project a full-year revenue expansion of approximately 6.0% and an adjusted EPS of $4.72 to $4.77, positioning the company for full-year profitability after historical losses.[23, 27, 28, 29]
During the Q1 2026 earnings materials, management expressed high confidence in meeting its "VISION 2027" strategic targets, which outline a revenue goal of $950 million to $1.0 billion and an adjusted EBITDA margin of 18.0%.[7, 19] In the first quarter of 2026, Adjusted EBITDA reached $35.38 million, representing 16.9% of net revenue, putting the company on a comfortable trajectory to hit the 18.0% target with seven quarters remaining.[4, 19]
A key catalyst highlighted by CEO Stephen Oswald is the upcoming Investor Day scheduled for September 17, 2026, in New York City, where the company plans to unveil its next five-year road map, "VISION 2032".[30] Additionally, management noted that remaining performance obligations (RPO) stood at a robust $1.074 billion, with a trailing twelve-month (LTM) book-to-bill ratio of 1.1x, heavily supported by surging missile program bookings.[7, 22]
A key event impacting Ducommun's financial reporting occurred on May 1, 2026, when management identified an error in its historical timing of stock-based compensation expense recognition.[24] The company failed to apply proper accounting under ASC 718 for retirement-eligible employees, where stock-based compensation should have been accelerated and fully recognized on the grant date rather than amortized over the standard vesting schedule.[24, 26]
As a result, Ducommun restated its audited financial statements for the fiscal years ended December 31, 2024, and December 31, 2025.[24, 26] The restatement revealed that operating income and net income were overstated by $10.0 million in FY2024, and by $3.4 million in FY2025.[24] Diluted EPS was restated downward by $0.65 for FY2024 and by $0.22 for FY2025.[24] Crucially, gross margins and revenues for both years were completely unaffected, and Adjusted EBITDA was only marginally impacted.[24]
Following the restatement, management admitted that its Internal Control over Financial Reporting (ICFR) was not effective as of December 31, 2025, prompting shareholder rights law firms to launch investigations into potential securities law violations.[24, 31, 32]
Furthermore, Ducommun’s FY2025 GAAP earnings were severely depressed by a massive, non-recurring $99.7 million subrogation litigation charge recorded in Q3 2025, stemming from a June 2020 fire at its performance center in Guaymas, Mexico.[33, 34] This lawsuit was permanently settled on January 7, 2026, with a confidential agreement requiring a cash payout of only $4.0 million to the insurer, representing a major cash conservation victory relative to the massive balance sheet accrual.[34]
To evaluate Ducommun's fundamental valuation, the historical financial performance across both segments must be contextualized. Over the last five years, Ducommun has expanded its top-line at a moderate pace, as shown in the consolidated revenue table below.
| Fiscal Period | Net Revenue (\$ Millions) | YoY Growth % | Net Income (\$ Millions) [GAAP] | Adjusted EBITDA Margin % |
|---|---|---|---|---|
| FY2021 | 645.1 [35] | -- | 15.9 [36] | 13.4% [37] |
| FY2022 | 712.5 [18, 35] | 10.4% [35] | 29.2 [36] | 13.3% [11] |
| FY2023 | 757.2 [35] | 6.3% [35] | 31.5 [37] | 14.8% [37] |
| FY2024 | 786.6 [35, 36] | 3.9% [37] | 21.7 [24] (Restated) | 14.8% [37] |
| FY2025 | 824.7 [2, 35] | 4.8% [35] | (37.4) [24] (Restated) | 16.4% [2] |
| Q1 2026 | 209.0 [19] | 8.6% [7] | 9.9 [19] | 16.9% [19] |
This historical trajectory yields a 5-year revenue compound annual growth rate (CAGR) of approximately 5.03%, calculated using the standard formula:
$CAGR = \left(\frac{V_{final}}{V_{initial}}\right)^{\frac{1}{n}} - 1$
$CAGR = \left(\frac{824.7}{645.1}\right)^{\frac{1}{4}} - 1 \approx 6.33\% \quad (\text{4-Year Growth from FY21 to FY25})$
$CAGR = \left(\frac{824.7}{629.0}\right)^{\frac{1}{5}} - 1 \approx 5.57\% \quad (\text{5-Year Growth from FY20 to FY25}) \quad [6, 35]$
While top-line growth has been moderate, valuation is heavily supported by margin expansion.[9] Adjusted EBITDA margins expanded by 310 basis points between FY2022 and FY2025, driven by a deliberate mix shift toward high-margin engineered products (now 23% of revenue) and the consolidation of its manufacturing facilities, which closed two high-overhead performance centers in Monrovia, California, and Berryville, Arkansas, yielding $11.0 million to $13.0 million in annualized savings.[2, 8, 12]
Currently, Ducommun trades at an Enterprise Value (EV) to Revenue multiple of 3.30x and Price to Sales of 2.95x, reflecting a premium to historical averages but a steep discount to the broader aerospace and defense average peer group of 5.5x.[38, 39, 40] This valuation discount is expected to contract as the company transitions to a highly visible missile and defense component play.[29]
High Impact |---------------------------------------------------------------------------------|
| * Boeing 737 MAX build rate freezes | * Multi-year contraction in US defense |
| * Commodity price spikes (Al, Ti) | budgets |
| | * Total loss of sole-source supplier |
| | status on key platforms |
|----------------------------------------|------------------------------------------|
| * Facility transition delays | * LTM Book-to-Bill drops below 0.95x |
| * Accrual of restatement legal fees | * Inability to pass through raw material |
| | inflation under fixed contracts |
Low Impact |---------------------------------------------------------------------------------|
Temporary Permanent / Long-Term
Risk Duration
* **What Could Go Wrong:** A prolonged regulatory or quality freeze on Boeing 737 MAX assemblies.[7, 42]
* **Early Warning Signs:** A decline in the LTM book-to-bill ratio below 1.0x (currently 1.1x) or an increase in days sales of inventory (DSI) beyond 110 days, indicating commercial inventory buildup and supply mismatches.[5, 7]
* **Long-Term Thesis Damage:** Permanent loss of preferred supplier status with Airbus or Raytheon, or a structural reduction in Department of Defense missile procurement budgets, which would disrupt the defense-driven growth engine.[5, 6, 41]
## 5. 5-Year Scenario Analysis
This scenario analysis projects Ducommun’s total shareholder return over a five-year horizon (FY2025 to FY2030), utilizing detailed operating inputs and capital structure bridges. The base year financials reflect Ducommun's restated FY2025 results, with an active share count of 15.09 million and a starting closing share price of $172.53 USD.[38, 43]
### Base Case Scenario (65% Probability)
* **Operating Assumptions:** Revenue expands at a 5-year CAGR of 7.5%, driven by accelerating missile program deliveries and a normalization of commercial aerospace destocking in late 2026.[7, 8] Net sales grow from $824.7 million in FY2025 to $1,183.92 million in FY2030.[2]
* **Margins and EBITDA:** The Adjusted EBITDA margin successfully reaches and stabilizes at the company's target of 18.0%, driven by higher utilization and cost savings from consolidated operations.[2, 19] This yields a Year 5 Adjusted EBITDA of $213.11 million.
* **Exit and Capital Structure Bridge:** We apply an EV/EBITDA multiple of 13.5x, reflecting historical defense-pure multiples.[29] Total enterprise value reaches $2,876.93 million. Free cash flow generation is utilized to reduce net debt to $150.0 million. Implied equity value is calculated as:
$\text{Implied Equity Value} = \text{Enterprise Value} - \text{Net Debt}$
$\text{Implied Equity Value} = \$2,876.93\text{M} - \$150.0\text{M} = \$2,726.93\text{M}$
Assuming minor share dilution results in 15.20 million diluted shares outstanding, the implied future share price is $179.40 USD, yielding a total five-year return of 3.98%.
### High Case Scenario (20% Probability)
* **Operating Assumptions:** Revenue grows at a 10.0% CAGR, fueled by rapid prime offloading, substantial defense contract wins, and Boeing and Airbus rate ramps.[5, 13] Net sales reach $1,328.18 million in FY2030.
* **Margins and EBITDA:** EBITDA margins expand to 19.5% due to a high-margin engineered products mix (exceeding the 25% target) and superior overhead absorption.[2, 8] Year 5 EBITDA reaches $259.00 million.
* **Exit and Capital Structure Bridge:** A premium EV/EBITDA multiple of 15.0x is applied, reflecting high-margin aerospace compounders.[16] This yields an EV of $3,885.00 million. Net debt is aggressively reduced to $100.0 million through robust free cash generation. Implied equity value reaches $3,785.00 million, which on 15.20 million shares yields a future share price of $249.01 USD, representing a total return of 44.33%.
### Low Case Scenario (15% Probability)
* **Operating Assumptions:** Revenue expands at a weak 4.0% CAGR due to prolonged commercial destocking, persistent Boeing build-rate delays, and cuts to US defense programs.[5, 41] Year 5 revenue is $1,003.35 million.
* **Margins and EBITDA:** Adjusted EBITDA margins contract and stagnate at 15.5% due to material inflation and under-absorption of fixed plant overhead.[5, 10] Year 5 EBITDA is $155.52 million.
* **Exit and Capital Structure Bridge:** The multiple contracts to a conservative 11.0x EV/EBITDA.[38] EV reaches $1,710.72 million. Net debt remains elevated at $250.0 million due to weak operational cash flow. Implied equity value falls to $1,460.72 million. Accounting for dilution, the share count rises to 15.50 million.[38] The future share price is projected at $94.23 USD, representing a negative total return of 45.38%.
### Probability-Weighted Target
Applying the subjective probability weights (65% Base, 20% High, 15% Low), the expected target value is:
$\text{Weighted Price Target} = (0.65 \times \$179.40) + (0.20 \times \$249.01) + (0.15 \times \$94.23) = \$180.54\text{ USD}$
This probability-weighted target price of $180.54 USD suggests a fundamental upside of 4.64% relative to the current market price of $172.53 USD.[43]
| Scenario | Revenue in Year 5 (\$M) | Margin / EBITDA Assumption % | Exit Multiple Assumption | Current Share Price (\$ USD) | Implied Future Share Price (\$ USD) | 5-year Total Return | Annualized Return | Probability |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| **High Case** | 1,328.18 [2] | 19.5% [19] | 15.0x [16] | 172.53 [43] | 249.01 | 44.33% | 7.61% | 20% |
| **Base Case** | 1,183.92 [2] | 18.0% [7] | 13.5x [29] | 172.53 [43] | 179.40 | 3.98% | 0.78% | 65% |
| **Low Case** | 1,003.35 [2] | 15.5% [38] | 11.0x [38] | 172.53 [43] | 94.23 | -45.38% | -11.23% | 15% |
| **Weighted** | **1,185.06** | **17.9%** | **13.2x** | **172.53** [43] | **180.54** | **4.64%** | **0.91%** | **100%** |
**TEMPERED VALUE COMPOUNDER**
## 6. Qualitative Scorecard
### Qualitative Evaluation Metrics
* **Management Alignment (7/10):** CEO Stephen Oswald holds a directly owned stake of 2.6% in the company, worth approximately $63.09 million, representing significant equity exposure.[44] The average management tenure is strong at 8.8 years.[44] However, the CEO’s total yearly compensation of $10.33 million is elevated relative to peers of similar size, and the compensation has increased during periods of GAAP unprofitability.[44] Furthermore, there has been notable insider selling activity over the past quarter.[44, 45]
* **Revenue Quality (8/10):** Backlog visibility is outstanding, with RPO remaining in excess of $1.07 billion.[7, 22] The structural shift toward high-margin engineered products (now 23% of revenue mix) and sole-source components enhances revenue defensibility.[2, 9] However, the severe customer concentration with Boeing, Airbus, and Raytheon prevents a higher score.[5]
* **Market Position (8/10):** Ducommun is successfully winning market share from defense incumbents through its prime offloading strategy.[13] Its sole-sourced positions on priority missile defense and standard narrowbody programs make it highly resilient, even amidst broader commercial aerospace supply chain disruptions.[7, 8]
* **Growth Outlook (8/10):** Surge demand for precision strike weapons and missile replenishment provides a highly visible, double-digit growth runway for the defense segment.[2, 7] The commercial segment is poised for sequential acceleration in late 2026 as inventory destocking headwind vectors ease.[8]
* **Financial Health (6/10):** Liquidity is sound, characterized by a current ratio of 2.04.[28] However, the balance sheet carries a substantial debt load of $345.83 million.[21] The May 2026 accounting restatements and associated ICFR material weaknesses are near-term overhangs that detract from overall financial health ratings.[24]
* **Business Viability (9/10):** Founded in 1849, Ducommun is California’s oldest continuously operating company, demonstrating unparalleled structural durability.[2] Its highly specialized manufacturing capabilities and deep-seated programmatic positioning on multi-decade defense programs insulate it from business disruption.[2, 6]
* **Capital Allocation (7/10):** The company has demonstrated solid execution on facility consolidations, and has historically achieved strong ROIC through targeted acquisitions of high-margin engineered products businesses.[2, 18] However, balance sheet deleveraging must be prioritized over aggressive mergers and acquisitions in the near term.[5]
* **Analyst Sentiment (9/10):** Sentiment remains exceptionally strong.[42] All five major Wall Street analysts covering the stock rate it as a Buy, with consensus price targets raised to an average of $164.00, ranging from $150 to $187.[27, 42, 45]
* **Profitability (7/10):** GAAP profitability was severely distorted in FY2025 due to the Mexico fire litigation settlement charge.[2, 33] However, adjusted profitability is excellent, with gross margins stabilizing at a record 26.90% and Adjusted EBITDA tracking comfortably toward the company's 18.0% target.[2, 19]
* **Track Record (8/10):** Since Oswald assumed leadership in 2017, Ducommun has successfully executed its transition to a higher-margin aerospace pure-play.[18] Over this tenure, the company's market capitalization has quadrupled, demonstrating a clear history of long-term shareholder value creation.[46]
### Scorecard Summary Table
| Metric | Score (1-10) | Key Factors |
| :--- | :---: | :--- |
| **Management Alignment** | 7 | CEO owns \$63M in stock [44], but high compensation relative to peers.[44] |
| **Revenue Quality** | 8 | Solid backlog visibility with \$1.07B RPO [7], offset by extreme customer concentration.[5] |
| **Market Position** | 8 | Gaining ground in defense offloading [13] with 30%+ factory headroom.[8] |
| **Growth Outlook** | 8 | Missile backlog at 4x book-to-bill [8], aerospace recovery in 2027.[19, 29] |
| **Financial Health** | 6 | Good short-term liquidity [28], but material weaknesses in internal controls.[24] |
| **Business Viability** | 9 | High-cost-of-failure components [1] and 176-year corporate history.[2] |
| **Capital Allocation** | 7 | Effective operational footprints, but elevated leverage requires debt reduction.[5] |
| **Analyst Sentiment** | 9 | Universally positive revisions post-earnings with targets up to \$187.[27, 45] |
| **Profitability** | 7 | Distorted by non-recurring items [33], but strong operational EBITDA margins.[2, 19] |
| **Track Record** | 8 | Strong multi-year compounder history under Mr. Oswald.[45, 46] |
| **Blended Score** | **7.7** | **A resilient strategic asset with localized execution and accounting risks.** |
**STRONG STRATEGIC MOAT**
## 7. Conclusion & Investment Thesis
Ducommun Inc. represents a compelling, highly defensive tier-component supplier story within the aerospace and defense sector. The company's strategic pivot under its "VISION 2027" program is delivering structural benefits, characterized by record gross profit margins and significant progress toward an 18.0% Adjusted EBITDA target.[7, 19] By shifting its product mix toward proprietary, high-margin engineered products and successfully capturing outsourced assemblies from capacity-constrained military primes, Ducommun has positioned itself as a core beneficiary of the ongoing geopolitical modernization cycle.[2, 13]
A core investment catalyst lies in the upcoming New York Investor Day on September 17, 2026, where the company plans to introduce its next five-year growth paradigm, "VISION 2032".[30] This event should serve as a major reassessment point for analysts to roll forward target valuations.[29] While commercial aerospace remains temporarily constrained by Boeing supply chain destocking, the defense segment’s missile franchise acts as a highly resilient buffer, backed by a robust $1.074 billion backlog.[7, 8, 22]
The primary risks are company-specific, including the resolution of the stock-based compensation restatement, remediation of internal financial reporting weaknesses, and the management of high customer concentration.[5, 24] However, given the massive exit-value discrepancy between the actual subrogation fire settlement ($4.0 million) and the prior balance sheet accrual ($99.7 million), Ducommun’s cash conservation outlook is highly favorable heading into the second half of 2026.[33, 34] At current valuation multiples of 3.3x revenue, the business remains significantly undervalued relative to aerospace compounders, representing a highly durable franchise with long-term margin runway.[38, 39]
**ROBUST AEROSPACE PLAY**
## 8. Technical Analysis, Price Action & Short-Term Outlook
Ducommun’s stock is in a powerful long-term uptrend, trading at $172.53 USD and sitting near its all-time high of $173.03 USD.[43] The share price resides 39.6% above its 200-day Simple Moving Average (SMA) of $116.24, confirming strong momentum.[47] Despite near-term volatility from class-action legal investigations, the short-term outlook remains highly constructive, with the price expected to find strong technical support at its 50-day SMA of $147.60 as investors digest the recent earnings beat.[25, 47]
**BULLISH MOMENTUM CONTINUES**
# Ducommun Inc (DCO) Investment Analysis matched exactly.## 1. Executive Summary, etc.) are implemented, avoiding internal bold formatting within the markdown headings.Catchy 1-3 Word Bold Summaries: Included at the end of sections 5, 6, 7, and 8.
Unsatisfied Requirements & Missing Details Addressed:
[source_id] format with a maximum of five source IDs per citation.View Ducommun Incorporated (DCO) stock page
Loading the interactive version of this report…